United States · FDA National Drug Code directory

Gabapentin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
87063-687_55115803-fea0-5de5-e063-6294a90a9f03
Product NDC
87063-687
Form
CAPSULE
Composition / generic term
Gabapentin
Labeler
ASCLEMED USA INC.
Marketing category
ANDA
Marketing start / end (source format)
20110129
Source listing expiry
20271231

Source-listed ingredients

  • GABAPENTIN — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 120 CAPSULE in 1 BOTTLE (87063-687-12) · 87063-687-12
  • 30 CAPSULE in 1 BOTTLE (87063-687-30) · 87063-687-30
  • 60 CAPSULE in 1 BOTTLE (87063-687-60) · 87063-687-60
  • 90 CAPSULE in 1 BOTTLE (87063-687-90) · 87063-687-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →